ReproMed
ReproMed is an Irish fertility clinic group operating five locations across Ireland, offering IVF, ICSI, IUI, egg freezing, donor gamete services, and PGT-A testing, and serving heterosexual couples, same-sex female couples, single women, and male-factor infertility patients.
- Company typePrivate
- Founded2015
- HeadquartersDundrum, Ireland
- Headcount51–100
- GTM typeB2C
- OfferingServices
What ReproMed does
ReproMed is an Irish fertility clinic group headquartered in Dundrum, Dublin, operating five clinic locations across Ireland (Dublin, Galway, Cork, Kilkenny, Drogheda). The clinic provides a comprehensive suite of assisted reproduction services including IVF, ICSI, IUI, TSI, egg freezing, donor egg and donor sperm programmes, PGT-A genetic testing, and shared parenthood/reciprocal IVF. Lab technology is anchored by ZYMOT microfluidic sperm selection, MACS magnetic-activated cell sorting, vitrification egg freezing, PGT-A, and advanced imaging (HyFoSy and transvaginal ultrasound); published success rates include a 60% donor egg live birth rate, 68.5% positive blastocyst frozen transfer for PGT-A, and 23.5% positive pregnancy test for IUI.
ReproMed is part of the FutureLife Group, a European reproductive medicine network, which gives it access to Ovumia (Finland) for identifiable egg donation and ISCARE (Prague) for anonymous egg donation abroad. Donor sperm is sourced through Cryos International and the European Sperm Bank. The clinic employs seven named fertility specialists plus an embryology and nursing team with 120+ combined years of clinical experience, and operates under multiple regulatory frameworks including EU Tissues and Cells Directive, Irish Statutory Instruments SI 158/2006 and SI 598/2007, the Children and Family Relationships Act 2015, and CHKS healthcare accreditation.
Revenue is generated primarily through per-cycle professional service fees for fertility treatments, plus recurring annual embryo and egg storage income. Treatment prices range from €155 (semen analysis) to €11,500 (in-house egg donation package). ReproMed participates in the HSE publicly funded IVF/ICSI/IUI scheme, accepts VHI health insurance, and offers Humm flexible payment plans and Access Fertility fixed-cost programmes to broaden access. Customer segments include heterosexual couples facing infertility, same-sex female couples, single women, and male-factor infertility patients — addressing conditions affecting approximately one in six couples in Ireland.
ReproMed firmographics
Firmographics- Name
- ReproMed
- Legal name
- ReproMed Holdings Ltd
- Website
- https://repromed.ie
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- ReproMed is an Irish fertility clinic group operating five locations across Ireland, offering IVF, ICSI, IUI, egg freezing, donor gamete services, and PGT-A testing, and serving heterosexual couples, same-sex female couples, single women, and male-factor infertility patients.
- Ownership category
- akta.pro rank
Where ReproMed is headquartered
LocationHeadquarters
- HQ city
- Dundrum
- HQ country
- Ireland
- HQ region
- Europe
Offices5 records
Markets served
ReproMed business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Fertility Treatment Services: ReproMed generates revenue from consultations, diagnostic tests, IVF/ICSI/IUI procedures, egg and embryo freezing/storage, and optional add-on services such as PGT-A genetic testing. Treatments are priced individually and may be covered partially by VHI health insurance or fully subsidised under the HSE publicly funded IVF/ICSI/IUI scheme.
- Donor Gamete Services: Revenue is generated from in-house egg donation (Ovumia partnership, basic package from €11,500), abroad anonymous egg donation (ISCARE partnership), and donor sperm services through Cryos International and European Sperm Bank.
- Storage and Long-term Services: Annual embryo and egg storage fees apply after the initial treatment cycle. First year of embryo storage is included in the egg donation package.
- Financing and Payment Plans: ReproMed offers Humm flexible payment plans and Access Fertility fixed-cost IVF programmes, acting as a channel to make treatments accessible to more patients.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | Egg Donation In-House Basic Package |
| One time/ perpetual license | Multi-year contract | Abroad Egg Donation (ISCARE) |
| Unit Pricing | Pay-as-you-go | EU Viral Screening |
| Unit Pricing | Pay-as-you-go | Initial Consultation |
| Unit Pricing | Pay-as-you-go | Semen Analysis |
| Unit Pricing | Pay-as-you-go | Exact Sperm DNA Test |
| Unit Pricing | Pay-as-you-go | Exact Sperm DNA Test & Semen Analysis |
Go-to-market motion1 record
Distribution channels5 records
Marketing channels6 records
ReproMed product offering
Product offeringCore offering
ReproMed is a full-service Irish fertility clinic delivering assisted human reproduction treatments including IVF, ICSI, IUI, TSI, egg freezing, donor egg and donor sperm programmes, shared parenthood/reciprocal IVF, PGT-A genetic testing, and fertility diagnostics. Treatments are performed at clinic locations in Dublin, Galway, Cork, Kilkenny and Drogheda, with selected donor pathways coordinated through FutureLife Group partners Ovumia (Finland) and ISCARE (Czech Republic).
Product overview
ReproMed is a fertility clinic offering a comprehensive range of assisted reproductive technology services. The core treatment services include IVF, ICSI, IUI, TSI (Timed Sexual Intercourse), and egg freezing. The clinic operates two egg donation programmes: the Ovumia In-House Identifiable Egg Donation Programme (with transfers in Dublin, ~60% success rate) and the ISCARE Abroad Anonymous Egg Donation Programme (with transfers in Prague, up to 65% success rate). Additional services include Shared Parenthood/Reciprocal IVF for female couples, PGT-A genetic testing, fertility assessments for males and females, viral screening, and donor sperm services. The clinic accepts HSE-funded treatments and offers flexible payment options. Services are delivered at clinics in Dublin and Galway.
Differentiator
Problem solved
Functional benefit
Products and services
- IVF (In Vitro Fertilisation) A fertility treatment where eggs are combined with sperm outside the body in a laboratory setting to achieve fertilisation, offered to heterosexual couples, same-sex couples, and single women experiencing difficulty conceiving.
- ICSI (Intracytoplasmic Sperm Injection) A specialised procedure where a single healthy sperm is injected directly into an egg to achieve fertilisation, particularly useful for male factor infertility, with ZYMOT microfluidic sperm selection included at no extra cost.
- IUI (Intrauterine Insemination) A procedure that places prepared sperm directly into the uterus to facilitate fertilisation, offered to heterosexual couples, same-sex female couples, and single women using donor sperm.
- Egg Freezing A process of extracting, freezing and storing a woman's eggs for use in later life using vitrification technology at -196°C, with over 90% egg survival rate post-thaw.
- Ovumia In-House Identifiable Egg Donation Programme An identifiable egg donation programme in partnership with Ovumia Finland where donor embryos are created and shipped to Ireland for frozen embryo transfer at ReproMed's Dublin or Galway clinics, with a basic package from €11,500.
- ISCARE Abroad Anonymous Egg Donation Programme An anonymous egg donation programme coordinated with ISCARE clinic in Prague, Czech Republic, with patients travelling overseas for fresh embryo transfer and achieving up to 65% pregnancy success rates per cycle.
- Shared Parenthood / Reciprocal IVF A programme for female couples where one partner carries the pregnancy and the other donates her eggs, allowing both partners to share in the IVF journey, with reported 60% positive pregnancy test rates in 2024-2025.
- TSI (Timed Sexual Intercourse) A treatment involving ultrasound and blood analysis to identify the most effective time for intercourse, often combined with ovulation induction.
- PGT-A (Preimplantation Genetic Testing for Aneuploidies) A genetic test performed during IVF to screen embryos for chromosomal abnormalities and select those with the correct number of chromosomes, with reported 68.5% positive blastocyst frozen transfer rate.
- Viral Screening EU-required blood tests for HIV, Hepatitis B and Hepatitis C screening priced at €175, valid for two years, conducted ahead of fertility treatment.
- Female Fertility Testing Assessment of hormone levels and ovarian health, including AMH testing and antral follicle count, to evaluate female fertility status.
- Male Fertility Testing Assessment of sperm health and male reproductive function, including semen analysis priced at €155.
- Exact Sperm DNA Test An advanced diagnostic test measuring sperm DNA fragmentation priced at €450 (or €605 combined with semen analysis), providing crucial information about male fertility potential.
- Donor Sperm Services Access to donor sperm from nominated sperm banks Cryos International and European Sperm Bank, with basic and extended profile options compliant with the Children and Family Relationships Act 2015.
- HSE Funded Fertility Treatments Government-funded IVF, ICSI and IUI treatments available through the HSE fertility programme, with eligibility expanded in Budget 2025 to include couples who already have a child.
Quantifiable outcome
- 60% live birth rate for donor eggs (Ovumia programme, all ages, 2023)
- +5 more outcomes
Companies that use ReproMed
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles1 record
ReproMed technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
ReproMed partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- Ovumia (FutureLife Group)coreReproMed collaborates with Ovumia in Finland, part of the FutureLife Group (a European leader in reproductive medicine and women's health), for its in-house identifiable egg donation programme. Donors are Finnish residents aged 20-35. Embryos are created via ICSI in Finland, frozen, and shipped back to Ireland where ReproMed performs frozen embryo transfers at its Dublin or Galway clinic. The programme achieves 60% live birth rates and has helped welcome over 15,000 babies through the FutureLife Group network.
- ISCARE (FutureLife Group)coreISCARE is ReproMed's sister IVF clinic in Prague, Czech Republic, and part of the same FutureLife Group. ReproMed coordinates the anonymous egg donation abroad programme for Irish patients, including initial consultations, diagnostics, paperwork, sperm shipping, and post-treatment aftercare. ISCARE performs over 1,000 IVF cycles annually and achieves up to 65% pregnancy success rates with anonymous egg donation. Patients travel to Prague for fresh embryo transfer.
- Cryos InternationalcoreCryos International is one of two nominated sperm banks that ReproMed works with for donor sperm. Donors are screened under the EU Tissue and Cell Directive. Cryos offers both Extended Profiles (including baby photos, personality tests, audio clips) and Basic Profiles (ethnicity, physical characteristics, education). Donors in Denmark can choose to be anonymous or non-anonymous (ID release at 18).
- European Sperm BankcoreEuropean Sperm Bank is ReproMed's second nominated sperm bank partner, providing donor sperm screened under EU Tissue and Cell Directive regulations. Compliant with the Children and Family Relationships Act 2015 which requires non-anonymous donors in Ireland.
- FutureLife GroupcoreFutureLife Group is a European leader in reproductive medicine and women's health, encompassing ReproMed Ireland, ISCARE Prague, and Ovumia Finland. The shared Group Medical Director oversees all programmes. The network has delivered over 15,000 babies and enables ReproMed to offer both domestic and international egg donation pathways.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
ReproMed competitors and assessment
Company assessmentDirect peers
- Sims IVF: Sims IVF is one of Ireland's largest fertility clinic networks, offering IVF, ICSI, IUI, and egg donation directly competitive with ReproMed across Dublin, Cork, Galway, and other Irish locations. Both serve the same HSE publicly funded and self-pay patient base.
- Beacon CARE Fertility: Beacon CARE Fertility is an Irish fertility clinic group with multiple locations offering IVF, ICSI, and donor programmes directly overlapping with ReproMed's service portfolio. Operates in the same Irish market with similar HSE/VHI funding pathways.
- Waterstone Clinic: Waterstone Clinic is an Irish fertility clinic offering IVF, ICSI, IUI and donor gamete services with multiple Irish locations. Directly comparable to ReproMed in scope, geography, and patient demographic.
- CREATE Fertility: CREATE Fertility is a UK-based fertility clinic chain offering IVF, ICSI, IUI, and mild stimulation protocols. Comparable specialist clinic model serving a similar patient demographic, with strong brand recognition in adjacent markets reachable from Ireland.
- Centre for Reproductive and Genetic Health (CRGH): CRGH is a London-based fertility clinic offering IVF, ICSI, PGT-A, and donor services. Comparable specialist fertility clinic serving similar patient demographics and using overlapping advanced technologies.
- London Women's Clinic: London Women's Clinic is a long-established UK fertility clinic offering a comprehensive IVF, ICSI, donor and genetic testing portfolio. Comparable specialist clinic with similar patient base and service range to ReproMed.
Broad incumbents
- The Fertility Partnership (TFP): TFP operates multiple UK fertility clinic brands offering IVF, ICSI, IUI, and donor programmes. A broader established player with portfolio approach across geographies, comparable service range but larger network footprint than ReproMed.
- IVI (IVIRMA Global): IVI is one of the world's largest fertility clinic networks with pan-European coverage. A broad incumbent offering the same IVF/ICSI/donor egg services as ReproMed across many countries, illustrating the relevant strategic peer archetype.
Others
- Ovumia (FutureLife Group): Ovumia is ReproMed's sister clinic within the FutureLife Group, providing identifiable egg donors for the in-house programme. Affiliated partner rather than competitor, but operates the same IVF/egg donation services, making it a strong operational peer for benchmarking success rates and clinical model.
Regional players
- Gennet: Gennet is a Czech fertility clinic network offering IVF, IUI, and donor services, frequently used by UK and Irish patients seeking cross-border fertility treatment. Operates in the same donor egg space that ReproMed accesses through its ISCARE Prague partnership.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
ReproMed social profiles
Digital presenceReproMed compliance and trust
Trust signalCompliance3 records
ReproMed financial estimates
Financial estimateRevenue estimate
Valuation estimate
ReproMed leadership team
Management profileNumber of profiles
Profiles7 records
ReproMed funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ReproMed M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ReproMed
What does ReproMed do?
ReproMed is a full-service Irish fertility clinic delivering assisted human reproduction treatments including IVF, ICSI, IUI, TSI, egg freezing, donor egg and donor sperm programmes, shared parenthood/reciprocal IVF, PGT-A genetic testing, and fertility diagnostics. Treatments are performed at clinic locations in Dublin, Galway, Cork, Kilkenny and Drogheda, with selected donor pathways coordinated through FutureLife Group partners Ovumia (Finland) and ISCARE (Czech Republic).
Is ReproMed a public or private company?
ReproMed is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was ReproMed founded?
ReproMed was founded in 2015. It employs 51 to 100 people.
Where is ReproMed based?
ReproMed is headquartered in Dundrum, Ireland, in the Europe region.
How does ReproMed make money?
Four revenue lines are on record. Fertility Treatment Services are the primary driver. The others are donor Gamete Services, storage and Long-term Services and financing and Payment Plans.
Who are ReproMed's main competitors?
Direct peers on record are Sims IVF, Beacon CARE Fertility, Waterstone Clinic, CREATE Fertility, Centre for Reproductive and Genetic Health (CRGH) and London Women's Clinic. Broad incumbents are The Fertility Partnership (TFP) and IVI (IVIRMA Global). Ovumia (FutureLife Group) is listed as an others. Gennet is listed as a regional player.
Does ReproMed have an API?
No public API is recorded for ReproMed.